MRK

Merck & Co Inc

Avantax Advisory Services Inc. lifted its stake in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 15.2% during the second quarter, according to its most recent filing with the Securities and...

Merck’s all-cash agreement grants it access to Cidara’s lead flu-prevention antibody, CD388, which has received FDA Breakthrough Therapy designation and is currently in late-stage studies enrolling more than 6,000 participants.

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Cidara Therapeutics, Inc. (NasdaqCM: CDTX) to...

Westpac Banking Corp lifted its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 2.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Thoroughbred Financial Services LLC lessened its position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 38.7% in the second quarter, according to its most recent disclosure with the...

WealthShield Partners LLC lessened its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 87.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities...

Generali Investments Management Co LLC grew its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 30.5% during the 2nd quarter, according to its most recent Form 13F filing with the...

Persistent Asset Partners Ltd bought a new position in Merck & Co., Inc. (NYSE:MRK - Free Report) in the 2nd quarter, according to its most recent filing with the SEC. The institutional investor...

Thomas Story & Son LLC purchased a new position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and...